New Delhi: India may get the much-talked-about nasal vaccine soon. It will act as a COVID-19 booster dose and protect from infection.
Speaking at the Times Now India@75: The Freedom Summit on Sunday, Dr Krishna Ella, chairman and managing director of Bharat Biotech, said the Hyderabad-based company is working on a combination of Covaxin followed by a nasal vaccine “so that Covaxin primes the system of innate immunity and then the boost by the nasal which produces three immune responses — the IGG, the IGA and then mucosal immunity, all three of which are powerful and can protect a person from getting infected,” Ella was quoted as saying.
The Serum Institute of India (SII) had last week said that a booster dose provides a four-fold increase in neutralising antibody levels.
Bhubaneswar: The Odisha government has handed over the investigation into the attack on Dhramasala MLA…
Bhubaneswar: The Commissionerate of Police on Sunday issued an advisory for movement of vehicular traffic…
New York: Now that President-elect Donald Trump has tasked Elon Musk with the responsibility of co-heading…
Bhubaneswar: The Odisha government has warned its employees of stern action for sub-letting their allotted…
Mumbai: There has been a lot of talk over AR Rahman and his wife Saira…
Sundargarh: The North Odisha Development Council (NODC) would be formed in 2-3 months, said Chief…
Puri: Director General of Police (DGP) YB Khurania on Sunday reviewed the security arrangements for…
Bhubaneswar: Three eminent personalities were conferred honorary D.Litt degrees for their outstanding academic excellence and…